Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west.

[1]  J. Jankowski,et al.  Barrett's metaplasia , 2000, The Lancet.

[2]  L J Schouten,et al.  Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. , 2000, International journal of epidemiology.

[3]  R. Sandler,et al.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus? , 2000, Gastroenterology.

[4]  A. Axon,et al.  Barrett's oesophagus: results from a 13‐year surveillance programme , 2000, European journal of gastroenterology & hepatology.

[5]  P. S. Rana,et al.  Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance. , 2000, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[6]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[7]  D. Johnston,et al.  Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? , 1997, The Lancet.

[8]  A. Wicks,et al.  Ten years’ experience of screening patients with Barrett’s oesophagus in a university teaching hospital , 1997, Gut.

[9]  H. Smart,et al.  Cost effectiveness of detecting Barrett's cancer. , 1996, Gut.

[10]  J. Hardcastle,et al.  Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. , 1992, Gut.

[11]  J. Mayberry,et al.  Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus , 1988, The British journal of surgery.

[12]  N. Barrett.  Chronic peptic ulcerz of the œophagus and ‘œsophagitis’ , 1950 .

[13]  J. Sloan,et al.  The incidence of adenocarcinoma in Barrett's oesophagus and an evaluation of endoscopic surveillance , 1991 .